CHF 18 billion invested in R&D in Switzerland in 2023
Neuchâtel, 14.1.2025 - In 2023, business enterprises invested CHF 18 billion in their R&D activities in Switzerland, an annual increase of 3.5% over 2021, which was the last time the survey was carried out. At almost CHF 5.5 billion, the 'pharmaceuticals' sector remains the biggest investor, despite an average annual decline of 6%. Nearly 69 000 people took part in R&D activities, a quarter of them women. These are the main results of a study carried out by the Federal Statistical Office (FSO) in partnership with economiesuisse.